z-logo
open-access-imgOpen Access
Anti‐Inflammatory Effects and Prediction of Blood Pressure Response by Baseline Inflammatory State in Catheter‐Based Renal Denervation
Author(s) -
Lang David,
Nahler Alexander,
Lambert Thomas,
Grund Michael,
Kammler Jürgen,
Kellermair Jörg,
Blessberger Hermann,
Kypta Alexander,
Steinwender Clemens,
Auer Johann
Publication year - 2016
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/jch.12844
Subject(s) - medicine , cystatin c , renal function , creatinine , denervation , blood pressure , white blood cell , urology , ambulatory blood pressure , inflammatory response , c reactive protein , endocrinology , gastroenterology , inflammation
This retrospective analysis aimed to examine off‐target effects on inflammatory and renal function parameters in n=78 subsequent patients treated with renal denervation ( RDN ) for resistant hypertension. Ambulatory and office blood pressure ( ABP / OBP ), serum creatinine, glomerular filtration rate ( GFR ), cystatin C, C‐reactive protein ( CRP ), interleukin‐6 ( IL ‐6), and white blood cell count ( WBC ) were assessed before, 6 and 12 months after RDN . ABP was significantly reduced by −8.2/−3.8 mm Hg ( P =.002/.021) at 1 year after RDN , while an initial OBP reduction was not sustained during follow‐up. IL ‐6 levels significantly decreased by −0.5 pg/mL ( P =.042) and by −1.7 pg/mL ( P <.001) at 6 and 12 months, baseline IL ‐6 levels possibly predicting ABP response to RDN ( r =−0.295; P =.020). Concurrently, leukocyte count was reduced by −0.5 × 10 3 /μL ( P =.017) and −0.8 × 10 3 /μL ( P <.001), respectively. Serum creatinine and GFR remained unchanged, but we observed a significant increase in cystatin C by 0.04 mg/L ( P =.026) and 0.14 mg/L ( P <.001) at 6 and 12 months after the intervention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here